Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06327750 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Microcirculation, Dialysis Modality and Sequestered Salt

Study acronym: MIMOSA
StatusRecruiting
PhaseNot applicable
Started2026-06-02
View on ClinicalTrials.gov ↗
The aim of this clinical trial is to investigate the effect of 5 different dialysis treatments (combinations of dialysis mode and dialysis fluid sodium content) on the microcirculation (MC) and sequestered sodium content (SSC) in adult prevalent end-stage kidney disease (ESKD) patients treated with hemodialysis (HD) or hemodiafiltration (HDF). The main questions it aims to answer are: 1. What are the effects on the sequestered sodium content and microcirculation after 4 weeks of treatment with the following dialysis modes? * HDF with an expected zero diffusive sodium balance (Dialysate sodium concentration (DNa)= Plasma sodium concentration (PNa)) compared to * HDF with an expected diffusive sodium efflux (DNa \< PNa, difference 3 mmol/L) compared to * HD with an expected zero diffusive sodium balance (DNa = PNa) compared to * HD with an expected diffusive sodium efflux (DNa \< PNa, difference 3 mmol/L) compared to * Isolated ultrafiltration for 30 minutes followed by HD with an expected zero diffusive sodium balance (DNa = PNa) 2. Are the SSC and MC interrelated in this patient group? This study is a randomized cross-over trial. Participants will be subjected to the abovementioned dialysis treatment modes in random order.

Amendment history 4 changes detected by DataLookout

2026-09-05
notable
Recruitment opened
2026-09-05
critical
Primary endpoint(s) modified
WasSequestered salt content (SSC), Skin microcirculation
NowSequestered salt content (SSC) in muscle
2026-09-05
notable
Primary completion pushed: 2027-12 → 2028-05
2026-09-05
minor
Completion pushed: 2027-12 → 2028-05
Trial Details
NCT Number NCT06327750
Lead Sponsor Amsterdam UMC, location VUmc
Collaborators: Dutch Kidney Foundation, Niercentrum aan de Amstel, B Braun Medical supplies trial fluids
Conditions End-stage Renal Disease
Enrollment 23 participants
Start Date 2026-06-02
Primary Completion 2028-05 (estimated)
Study Completion 2028-05 (estimated)
Updated on ClinicalTrials.gov 2026-09-04